PFSA
NASDAQProfusa
$5.46
-2.11 (-27.87%)
2026-08-21 00:00
Healthcare
Medical Devices
--
--
Short Interest (1 Year)
% of Volume Sold ShortMarket Cap
$551K
P/E Ratio
N/A
52W Low
52W High
$0.05
$28.32
Volume
617K
About Profusa
Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berk...
Website
profusa.com
Financial Highlights
Annual
Quarterly
| Year | Revenue | Op Margin | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2025 | N/A | N/A% | -$35.8M | -$16.2M |
| 2024 | N/A | N/A% | -$9.2M | -$2.1M |
| 2023 | N/A | N/A% | -$10.3M | -$4.4M |
| 2022 | N/A | N/A% | -$20.2M | -$7.7M |
| 2021 | N/A | N/A% | -$10.3M | -$10.7M |
| 2026 Q1 | N/A | N/A% | -$3.5M | -$2.6M |
| 2025 Q4 | N/A | N/A% | -$8.6M | -$5.1M |
| 2025 Q3 | N/A | N/A% | -$22.2M | -$10.6M |
| 2025 Q2 | N/A | N/A% | -$8.2M | -$139K |
| 2025 Q1 | N/A | N/A% | -$2.7M | -$537K |
| 2024 Q4 | N/A | N/A% | -$7.6M | -$328K |
| 2024 Q3 | $75K | -1470.7% | -$2.5M | -$1.2M |
| 2024 Q2 | N/A | N/A% | -$397K | -$395K |